复星医药是做什么的

Fosun Pharma is an innovative global healthcare ecosystem player. It is committed to patient-centered and clinically driven developments. With a focus on first-in-class (FIC) and best-in-class (BIC) products, Fosun Pharma enriches its product pipeline through independent research and development, collaborative development, licensing, and deep incubation.

1. Overview of Fosun Pharma

Fosun Pharma is engaged in drug manufacturing and R&D, medical services, medical diagnosis and medical devices, and pharmaceutical distribution and retail. Among them, drug manufacturing and R&D are the core areas, with medical services as a key focus. In 2020, the company achieved operating revenue of 30.307 billion yuan, a year-on-year increase of...

2. Establishing Shanghai Fosun Pharma Development Co., Ltd.

Shanghai Fosun Pharma Development Co., Ltd. was established on November 27, 2001, with Wu Yifang as its legal representative. Its business scope includes licensed projects such as drug wholesale, import and export of goods and technologies, and drug contract manufacturing (subject to approval as required by law)...

3. Star Product Axilumab

Axilumab, a star product of Fosun Pharma, was developed by its joint venture company Fosun Kite. In June 2021, it became the first CAR-T cell therapy product to be approved and launched in China. As of the end of February 2022, there have been approximately hundreds of patients...

4. Comprehensive Business Coverage

Fosun Pharma is the only A-share listed company in China that has grown through mergers and acquisitions and expanded internationally. Its business covers the entire medical industry, including pharmaceuticals, medical devices, medical diagnostics, and pharmaceutical distribution. Due to its diverse business portfolio, the valuation of Fosun Pharma is complex, and it is difficult to provide an exact valuation...

5. Fosun Pharma's Main Business Operations

Fosun Pharma's main business operations, industry revenue composition, product revenue composition, and regional revenue composition can be comprehensively understood through the analysis provided by Winfoc.com. This enables investors to grasp the company's operating situation...

6. Analysis of Pharmaceutical and Medical Device Business

In terms of revenue, Fosun Pharma's income mainly comes from pharmaceuticals, medical devices, medical diagnostics, and medical health services. In terms of pharmaceutical business, the company has built a comprehensive...

7. Future Market Expectations

Fosun Pharma will undoubtedly provide a reassurance to the market, which is currently pessimistic about the overall domestic pharmaceutical industry. In addition to vaccines and innovative biopharmaceuticals (Fosun Pharma HanAll BioPharma), Fosun Pharma also has...

通过以上内容可以出以下内容：

内容1：复星医药以患者为中心、临床需求为导向进行自主研发、合作开发等方式来丰富产品线，并提升同类首创与最佳产品的比例。内容2：复星医药主要从事药品制造与研发、医疗服务、医学诊断与医疗器械、医药分销与零售业务，其中以药品制造与研发为主。内容3：复星医药成立于2001年，主要经营范围包括药品批发、货物进出口、技术进出口和药品委托生产等。内容4：复星医药的明星产品是阿基仑赛注射液，是***国内首个上市的CAR-T细胞治疗产品。内容5：复星医药是A股上市中唯一一家通过并购做大并走出国门的企业，业务涵盖制药、医疗器械、医疗诊断和医药流通等领域。内容6：复星医药的营业收入主要来自制药、医疗器械、医学诊断和医疗健康服务等业务。内容7：未来市场对复星医药的预期较高，尤其是在疫苗和生物创新药方面。